FDA makes history, approves Elevidys to treat pediatric Duchenne muscular dystrophy
The U.S. Food and Drug Administration approved Elevidys in June, making it the first gene therapy designed to treat pediatric Duchenne muscular dystrophy, a life-threatening genetic disorder of progre...
read more